Following the success of Tony Russell’s UTI article, it seems apparent that implementing new identifiers will be a major area of difficulty prior to the start of OTC/ETD trade reporting in Februrary 2014. The presentation below sets out the details of the proposals for the UPI and UTI, identifies some of the major issues and draws links between the three unique identifiers.
RegRisk Legal Solutions Limited has taken all reasonable care and skill in the compilation of this guidance. However, it shall not be under any liability for loss or damage (including consequential loss) whatsoever or howsoever arising as a result of errors or omissions or the use of this publication by the users, whomever they may be. RegRisk Legal recognises that some of the terms appearing in this report are proprietary. All such trademarks are acknowledged and every effort has been made to indicate them by the normal UK publishing practice of capitalisation. The presence of a term in whatever form does not affect its legal status as a trademark.